The vector of anti-gp33 T cell receptor (TCR) is constructed for the engineering of T cell to target LCMV gp33. The T cells are genetically modified through transduction with a retroviral vector expressing gp33-specific T cell receptor. And the vector product was designed for the treatment of lymphocytic choriomeningitis virus infection.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|TCR-L259||Mouse anti-gp33 T cell receptor (P14), pCDTCR1|
|TCR-L035||Human anti-gp33 (KAVYNFATM) T Cell Receptor, pMP71|
|TCR-L034||Human anti-gp33 (KAVYNFATM) T Cell Receptor, pMSGV1|
|TCR-L035Z||Human anti-gp33 (aa1-9) T cell receptor, pCDTCR1|
|TCR-L036Z||Mouse anti-gp33 (aa1-9) T cell receptor, pCDTCR1|
|TCR-L034Z||Human anti-gp33 T cell receptor, pCDTCR1|
|VP-TCR-C169||Lenti-gp33 T cell receptor (P14) Viral Particle|
|TCR-C085Z||Mouse anti-gp33 (KAVYNFATM) T cell receptor (P14), pCDTCR1|
|VP-TCR-C168||Lenti-gp33 (KAVYNFATM) T cell receptor (P14) Viral Particle|
|VP-TCR-C167||Lenti-gp33 (KAVYNFATC) T cell receptor (P14) Viral Particle|
Copyright © 2007 - 2017 Creative Biolabs. All Rights Reserved